drug-targets
100,000 structures
Takeda joins drug target discovery initiative
Illuminating the ‘druggable genome’
Prioritising cancer drug targets using CRISPR
CRISPR offers new insights into critical cancer changes
Deciphering suitable cancer drug combinations
The PROTACtable genome – a new route to drug discovery
